ORIC Pharmaceuticals

ORIC Pharmaceuticals

ORIC

Reported
Thursday, March 16

Q4 2022 Earnings

(USD)ExpectedReportedSurprise $Surprise %
EPS-0.55-0.520.035.45%
Revenue-0.00--
WhatIF - Earnings
EPS Beat Expectations by $0.03
emptyImageAlt
ORIC Pharmaceuticals (ORIC:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything